 |
||
公告翻譯節(jié)選
Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
香港交易及結算所有限公司及香港聯(lián)合交易所有限公司對本公告之內(nèi)容概不負責，對其準確性或完整性亦不發(fā)表任何聲明，并明確表示概不就因本公告全部或任何部分內(nèi)容而產(chǎn)生或因倚賴該等內(nèi)容而引致之任何損失承擔任何責任。
The Board is pleased to announce that on 18 January 2013, ABC and the Purchaser entered into the Provisional Agreement, pursuant to which ABC has agreed to sell, and the Purchaser has agreed to purchase, the Property at the Consideration of HK$66,800,000.
董事會欣然宣布，于二零一三年一月十八日，ABC與買方訂立臨時協(xié)議，據(jù)此，ABC同意出售而買方同意購買該物業(yè)，代價為66,800,000港元。
The Disposal constitutes a discloseable transaction for the Company and is subject to notification and announcement requirements of Chapter 14 of the Listing Rules.
出售事項構成本公司之須予披露交易，并須符合上市規(guī)則第14章之通告及公告規(guī)定。
The Group is an investment company with core businesses in both the medical and non-medical sectors. The Group’s business activities can be broadly categorised into the (i) provision of medical and dental services, health check and pharmaceutical businesses; and (ii) securities and property investment business. The Group also holds investment in companies which are principally engaged in sale of healthcare and pharmaceutical products businesses in the PRC.
本集團為一間投資公司，核心業(yè)務涵蓋醫(yī)療及非醫(yī)療分部。本集團之業(yè)務活動大致可分為(i)提供醫(yī)療及牙科服務、體檢及醫(yī)藥業(yè)務；及(ii)證券及物業(yè)投資業(yè)務。本集團亦投資主要于中國從事銷售醫(yī)藥產(chǎn)品業(yè)務之公司。
Upon Completion, the Group expects to recognise an unaudited accounting gain of approximately HK$8,800,000, being the difference between the Consideration and the estimated net asset value of the Property at Completion. The actual gain or loss as a result of the Disposal to be recorded by the Group is subject to audit and will be determined as at the date of the Completion.
完成后，本集團預期確認未經(jīng)審核會計收益約8,800,000港元（即代價與該物業(yè)于完成時之估計資產(chǎn)凈值之差額）。本集團將因收購事項而錄得之實際收益或虧損有待審核并將于完成日期厘定。
